AU2002364260A1 - Avb3 and avb5 integrin antagonists and methods of treating diseases or conditions associated with avb3 and avb5 integrins - Google Patents

Avb3 and avb5 integrin antagonists and methods of treating diseases or conditions associated with avb3 and avb5 integrins

Info

Publication number
AU2002364260A1
AU2002364260A1 AU2002364260A AU2002364260A AU2002364260A1 AU 2002364260 A1 AU2002364260 A1 AU 2002364260A1 AU 2002364260 A AU2002364260 A AU 2002364260A AU 2002364260 A AU2002364260 A AU 2002364260A AU 2002364260 A1 AU2002364260 A1 AU 2002364260A1
Authority
AU
Australia
Prior art keywords
avb3
avb5
methods
conditions associated
treating diseases
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002364260A
Inventor
Catherine Brennan
Julie Dixon
Jacques Dumas
Barry Hart
Holia Hatoum-Mokdad
Jeffrey Johson
Uday Khire
Peying Liu
Aniko Redman
William J. Scott
Robert Sibley
Jill Wood
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharmaceuticals Corp
Original Assignee
Bayer AG
Bayer Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer AG, Bayer Corp filed Critical Bayer AG
Publication of AU2002364260A1 publication Critical patent/AU2002364260A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00—Sulfones; Sulfoxides
    • C07C317/44—Sulfones; Sulfoxides having sulfone or sulfoxide groups and carboxyl groups bound to the same carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C335/00—Thioureas, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C335/04—Derivatives of thiourea
    • C07C335/16—Derivatives of thiourea having nitrogen atoms of thiourea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C335/18—Derivatives of thiourea having nitrogen atoms of thiourea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by singly-bound oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07—Optical isomers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/02—Systems containing only non-condensed rings with a three-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/04—Systems containing only non-condensed rings with a four-membered ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2002364260A 2001-12-31 2002-12-31 Avb3 and avb5 integrin antagonists and methods of treating diseases or conditions associated with avb3 and avb5 integrins Abandoned AU2002364260A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US34572601P 2001-12-31 2001-12-31
US60/345,726 2001-12-31
PCT/US2002/041692 WO2003059872A1 (en) 2001-12-31 2002-12-31 Avb3 and avb5 integrin antagonists and methods of treating diseases or conditions associated with avb3 and avb5 integrins

Publications (1)

Publication Number Publication Date
AU2002364260A1 true AU2002364260A1 (en) 2003-07-30

Family

ID=23356231

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002364260A Abandoned AU2002364260A1 (en) 2001-12-31 2002-12-31 Avb3 and avb5 integrin antagonists and methods of treating diseases or conditions associated with avb3 and avb5 integrins

Country Status (2)

Country Link
AU (1) AU2002364260A1 (en)
WO (1) WO2003059872A1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100697612B1 (en) * 2001-07-27 2007-03-22 주식회사유한양행 4-Phenyl-3-cyclobutene-1,2-dione derivatives and processes for the preparation thereof
GB0406378D0 (en) * 2004-03-22 2004-04-21 Karobio Ab Novel pharmaceutical compositions
CA2704199C (en) * 2007-11-01 2016-01-19 Acucela Inc. Amine derivative compounds for treating ophthalmic diseases and disorders
WO2010048332A2 (en) 2008-10-22 2010-04-29 Acucela, Inc. Compounds for treating ophthalmic diseases and disorders
CA2986195A1 (en) 2009-03-25 2010-09-30 Abbvie Inc. Substituted aryl antivrial compounds and uses thereof
US20130273034A1 (en) 2010-09-03 2013-10-17 Kenneth W. Bair Novel compounds and compositions for the inhibition of nampt
WO2015009948A1 (en) 2013-07-19 2015-01-22 Regents Of The University Of California Milk fat globule epidermal growth factor 8 regulates fatty acid uptake
CN110128299B (en) * 2019-05-13 2020-11-10 浙江大学 Diphenylurea antitumor small-molecule inhibitor and preparation method thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT889876E (en) * 1996-03-29 2001-11-30 Searle & Co META-REPLACED PHENYLENESULFONAMID DERIVATIVES

Also Published As

Publication number Publication date
WO2003059872A1 (en) 2003-07-24

Similar Documents

Publication Publication Date Title
ZA200305825B (en) Modified antibodies and methods of use
IL164784A0 (en) Diaryl urea derivatives useful for the treatment of protein kinase dependent diseases
ATE420659T1 (en) CRIPTO-BLOCKING ANTIBODIES AND THEIR USE
GB0526424D0 (en) Triboelectric, ranging, or dual use security sensor cable and method of manufacturing same
FI20012426A0 (en) Composite nonwoven, its use and the method of making it
HUP0105490A3 (en) Epitopes or mimotopes derived from the c-epsilon-3 or c-epsilon-4 domains of ige, antagonists thereof, and their therapeutic uses
EP1476469A4 (en) MONOCLONAL ANTIBODIES AGAINST EXTRACELLULAR LOOPS OF C5aR
EP1182451A4 (en) Biosensor and method of producing the same
ITMO20030070A0 (en) IMPROVED SNAP HINGE FOR CLOSING ELEMENTS OF COMPARTMENTS AND SIMILAR.
AU2002364260A1 (en) Avb3 and avb5 integrin antagonists and methods of treating diseases or conditions associated with avb3 and avb5 integrins
AU2003277215A1 (en) Novel neurokinin antagonists and methods of use thereof
EP1403369A4 (en) Method of evaluating the function of phagocyte and utilization thereof
HK1066786A1 (en) Preparation process of some halogeno-substituted monosulfides and their hydroxy-monosulfide or isothiouronium bromide equivalents as intermediates
IL145024A0 (en) Epitopes or mimotopes derived from the c-epsilon-2 domain of ige, antagonists thereof, and their therapeutic uses
AU2001225372A1 (en) Bicyclic heteroaryl compounds as inhibitors of the interaction between the integrin alpha4beta1 receptor and vcam-1 and/or fibronectin
AU2003276844A8 (en) Formulations of modified antibodies and methods of making the same
DE59900317D1 (en) CVD REACTOR AND THEIR USE
EP1631311A4 (en) Humanized anti-ccr2 antibodies and methods of use
EP1612438A4 (en) Constant velocity joint and method of manufacturing the same
DE69933035D1 (en) ANTICARIOGENIC MILK PRODUCT AND ITS USE
AU2003279889A8 (en) Electromagnetic wave trasmitter systems, methods and articles of manufacture
AU2003293354A8 (en) Substituted pyridines or pyrimidines, method for their production, agents containing said substances and the use thereof as pesticides
EP1691091A4 (en) Constant velocity joint and method of manufacturing the same
AU2003249364A8 (en) Algal gdp-mannose-3',5'-epimerases and methods of use thereof
GB2405511B (en) Door alarm, doorway and use of the alarm

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase